Table 1.
Figure | Treatment | EC50 | Rmax (% changed) |
---|---|---|---|
3A | 2.2 nM TSP1 | 9.288E−08 | 64.90 |
0.22 nM TSP1 | 1.802E−07 | 77.18 | |
Control | 7.321E−08 | 100.00 | |
3B | 2.2 nM E123CaG1 | 3.549E−07 | 82.11 |
Control | 3.109E−07 | 100.00 | |
3C | 2.2 nM TSP1 | 6.225E−09 | 96.04 |
Control | 1.854E−09 | 100.00 | |
4A | WT | 2.104E−07 | 87.24 |
TSP1 null | 2.249E−07 | 126.14 | |
4B | TSP1 null | 1.532E−07 | 100.00 |
TSP1 null +2.2 nM TSP1 | 2.499E−07 | 82.86 | |
4C | CD47 | 5.542E−07 | 100.00 |
CD47 +2.2 nM TSP1 | 4.453E−07 | 82.01 |